The MaxDiscovery™ Alkaline Phosphatase ELISA Kit is an enzyme immunoassay that analyzes the quantity of alkaline phosphatase in human cells, tissues, serum or urine. Alkaline phosphatase is a well known hydrolase enzyme responsible for removing phosphate groups from molecules including nucleotides, proteins and alkaloids. In humans, alkaline phosphatase is present in all tissues throughout the body, but is concentrated in the liver, bile duct, kidney, bone and placenta. The normal range of alkaline phosphatase is 44-147 IU/L. High alkaline phosphatase levels can show that the bile ducts are blocked. Levels are significantly higher in children and pregnant women. Also, elevated alkaline phosphatase indicates that there could be active bone deposition occurring as alkaline phosphatase is a by-product of osteoblast activity. Like most ELISA assays, the MaxDiscovery™ Alkaline Phosphatase ELISA Kit relies on a Horseradish Perioxidase (HRP) conjugated antibody and the TMB (3,3´,5,5´-tetramethylbenzidine) substrate. TMB is a chromogen that yields a blue color when oxidized with hydrogen peroxide (catalyzed by HRP) that has major absorbances at 370 nm and 652 nm. The color then changes to yellow with the addition of acid with maximum absorbance at 450 nm. The relative amount of alkaline phosphatase protein in the cells will be directly proportional to the amount of signal that is obtained at 450 nm. This kit contains materials for the extraction and quantitative detection of the alkaline phosphatase protein in cells, serum, tissues or urine.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.